Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38446675

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2024 Mar 7
First author
Powles T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Powles T
      type
      Author
    2. name
      Valderrama BP
      type
      Author
    3. name
      Gupta S
      type
      Author
    4. name
      Bedke J
      type
      Author
    5. name
      Kikuchi E
      type
      Author
    6. name
      Hoffman-Censits J
      type
      Author
    7. name
      Iyer G
      type
      Author
    8. name
      Vulsteke C
      type
      Author
    9. name
      Park SH
      type
      Author
    10. name
      Shin SJ
      type
      Author
    11. name
      Castellano D
      type
      Author
    12. name
      Fornarini G
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Powles T
      type
      Author
    2. name
      Valderrama BP
      type
      Author
    3. name
      Gupta S
      type
      Author
    4. name
      Bedke J
      type
      Author
    5. name
      Kikuchi E
      type
      Author
    6. name
      Hoffman-Censits J
      type
      Author
    7. name
      Iyer G
      type
      Author
    8. name
      Vulsteke C
      type
      Author
    9. name
      Park SH
      type
      Author
    10. name
      Shin SJ
      type
      Author
    11. name
      Castellano D
      type
      Author
    12. name
      Fornarini G
      type
      Author
    bibliography ids
    1. nci-bib-e1ba51364a42e6edc55fd9a3
    book metadata
    content sha256
    54a9c90a7c867fe6d7280de73a6d13eee21db0f2d0058e26c411185a627acc36
    document type
    citation
    dois
    1. 10.1056/NEJMoa2312117
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38446675
    immutable id
    pubmed:38446675@54a9c90a7c867fe6d7280de73a6d13eee21db0f2d0058e26c411185a627acc36
    journal
    abbreviation
    N Engl J Med
    issn electronic
    1533-4406
    issn print
    0028-4793
    issue
    10
    name
    The New England journal of medicine
    nlm unique id
    0255562
    pages
    875-888
    volume
    390
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38446675
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      269c9741b5140baa9c340539fa88d713bae5ecd854a252bfc27d93afb61d6b26
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Mar 7
      precision
      day
      year
      2024
      publication types
      1. Clinical Trial, Phase III
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38446675/
      title
      Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.

      Preserved source evidence · Not medical advice